Sangamo BioSciences, Inc. · Richmond, CA United States (NASDAQ: SGMO)
| Point Richmond Tech Center Ii, 501 Canal Blvd., Ste. A100 | Phone: 510-970-6000 |
| Richmond, CA | Fax: 510-236-8951 |
| 94804 | |
| United States | 
Map This Company |
Sangamo BioSciences, Inc. Rankings
More Companies in These Related Industries: Biologics MfgCompany Description
Sangamo BioSciences hopes zinc fingers have the Midas touch when it comes to regulating gene expression. The company's zinc finger DNA-binding proteins (ZFPs) control gene expression (activation) and cell function; the firm aims to develop gene-correcting therapeutics for a variety of indications, including neurological conditions, infectious diseases, cancer, and cardiovascular disease. Sangamo BioSciences has candidates in clinical trials and research stages for conditions such as diabetic neuropathy (nerve damage), Lou Gehrig's disease, HIV/AIDS, and brain cancer. Other ZFP development programs include research in the areas of Parkinson's disease, neuropathic pain, stroke, and spinal cord injury.
Sangamo BioSciences, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: SGMO Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 81 |
Executives
23 executives listed for Sangamo BioSciences, Inc.'s Richmond, CA location.
| Chairman | William Ringo | |
|---|---|---|
| President, CEO, and Director | Edward Lanphier | |
| EVP and CFO | H. Ward Wolff |